Kaveri Pohlman
Stock Analyst at BTIG
(0.28)
# 4,141
Out of 4,873 analysts
21
Total ratings
22.22%
Success rate
-19.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $1.36 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $20.74 | +126.62% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $7.84 | +282.90% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $8.27 | +359.49% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.05 | +143.90% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $23.35 | +165.52% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $1.28 | +525.00% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $45.72 | -40.94% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $8.75 | +700.00% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.03 | +1,065.05% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $2.14 | +273.83% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $1.17 | +421,096.58% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.36
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $20.74
Upside: +126.62%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $7.84
Upside: +282.90%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $8.27
Upside: +359.49%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.05
Upside: +143.90%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $23.35
Upside: +165.52%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.28
Upside: +525.00%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $45.72
Upside: -40.94%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $8.75
Upside: +700.00%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.03
Upside: +1,065.05%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $2.14
Upside: +273.83%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $1.17
Upside: +421,096.58%